InMed Pharmaceuticals Inc (INM) — Tangible Net Worth Ratio
InMed Pharmaceuticals Inc (INM) has a Tangible Net Worth Ratio of 100.0% as of June 2026. This metric is calculated by deducting intangible assets ($0.00) from net assets ($1.08 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore net asset growth rate of InMed Pharmaceuticals Inc to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
InMed Pharmaceuticals Inc Tangible Net Worth Ratio (2001–2026)
This chart shows how InMed Pharmaceuticals Inc's Tangible Net Worth Ratio has changed across 18 annual periods from 2001 to 2026. As of June 2026, the ratio stands at 100.0%, reflecting net assets of $1.08 Billion with intangible assets of $0.00 USD. For live market cap and overall valuation, see InMed Pharmaceuticals Inc (INM) market capitalisation.
Annual Tangible Net Worth Ratio for InMed Pharmaceuticals Inc (2001–2026)
The table below presents the year-by-year Tangible Net Worth Ratio for InMed Pharmaceuticals Inc from 2001 to 2026, covering 18 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. Explore InMed Pharmaceuticals Inc (INM) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2026 | 100.0% | $1.08 Billion | $0.00 | $3.03 Billion | ▲ +12.1 pp |
| 2025 | 87.9% | $18.30 Million | $2.21 Million | $21.23 Million | ▲ +7.3 pp |
| 2024 | 80.6% | $12.59 Million | $2.44 Million | $16.17 Million | ▼ -3.3 pp |
| 2023 | 83.9% | $16.02 Million | $2.58 Million | $18.69 Million | ▲ +7.1 pp |
| 2022 | 76.8% | $11.69 Million | $2.72 Million | $16.46 Million | ▼ -8.8 pp |
| 2021 | 85.6% | $9.12 Million | $1.31 Million | $12.10 Million | ▲ +4.1 pp |
| 2020 | 81.5% | $5.88 Million | $1.09 Million | $7.80 Million | ▼ -12.0 pp |
| 2019 | 93.5% | $13.88 Million | $902.44K | $15.07 Million | ▼ -1.8 pp |
| 2018 | 95.3% | $20.62 Million | $968.42K | $21.34 Million | ▲ +12.4 pp |
| 2017 | 82.9% | $6.13 Million | $1.05 Million | $6.41 Million | ▲ +120.3 pp |
| 2016 | -37.5% | $820.48K | $1.13 Million | $1.28 Million | ▼ -48.8 pp |
| 2015 | 11.3% | $1.28 Million | $1.13 Million | $1.34 Million | ▲ +3.6 pp |
| 2014 | 7.7% | $1.52 Million | $1.40 Million | $1.59 Million | ▼ -92.3 pp |
| 2012 | 100.0% | $2.72K | $0.00 | $47.31K | ▲ +0.0 pp |
| 2011 | 100.0% | $202.29K | $0.00 | $248.50K | ▲ +288.4 pp |
| 2003 | -188.4% | $241.85K | $697.54K | $1.16 Million | ▼ -288.3 pp |
| 2002 | 99.9% | $1.29 Million | $1.02K | $1.36 Million | ▲ +0.0 pp |
| 2001 | 99.9% | $4.18 Million | $4.10K | $4.67 Million | — |